A novel approach to measuring response and remission in schizophrenia in clinical trials
Year: 2017
Type: review
Source: Schizophrenia Research
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: FORUM Pharmaceuticals, Alkermes
OpenAlex ID: W2605477248
